Ludwig-supported researchers located at the de Duve Institute of the Université catholique de Louvain study tumor immunology, the tumor microenvironment and the aberrant signaling that drives myeloproliferative neoplasms and acute myeloid leukemia.
Ludwig scientists in Brussels also hold partial appointments at the Ludwig Branch at the University of Oxford, where they are conducting collaborative research on the tumor microenvironment, cancer vaccines and the epigenetics of blood cancer progression into acute malignancy.
Ludwig Institute for Cancer Research, Brussels
Avenue Hippocrate 74, Bte B1.74.03
Brussels, BRU, BE, 1200
Belgium
T 32 2 764 7459
